Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 179   

Articles published

AZN 4,301.00 -15.50 (-0.36%)
price chart
3 Stocks To Avoid In A Plunging Market: AstraZeneca plc, Centrica PLC ...
The FTSE 100 index rallied on Friday and is in positive territory on Monday after two volatile trading sessions last week. Shareholders of AstraZeneca (LSE: AZN), Centrica (LSE: CNA) and Thomas Cook (LSE: TCG) are going to be in trouble if market ...
Can AstraZeneca plc Help You To Retire Rich?
It's been an incredible turnaround for investors in AstraZeneca (LSE: AZN) (NYSE: AZN.US) in recent years. Indeed, after posting next to no share price gains between 2010 and 2013, shares in the pharmaceutical major have risen by 49% since the start of ...
Is AstraZeneca plc A Safe Dividend Investment?
At a share price of 4351p the firm's forward P/E rating stands at just under 18 for 2015, which seems high for a company expected to show a decline in earnings of 7% that year.
AstraZeneca plc's "Neutral" Rating Reiterated at Credit Suisse (AZN)
AstraZeneca plc (ADR) logo Credit Suisse reissued their neutral rating on shares of AstraZeneca plc (NYSE:AZN) in a research report released on Thursday morning.
AstraZeneca plc Given Average Rating of "Hold" by Analysts (LON:AZN)  Ticker Report
AstraZeneca plc's "Buy" Rating Reaffirmed at Nordea Equity ...  Watch List News (press release)
Related articles »  
GlaxoSmithKline plc Is Still A Better Pick Than AstraZeneca plc
AstraZeneca It has been a terrible year for GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and more bad news could be around the corner.
Related articles »  
AstraZeneca plc (AZN) - Research Analysts' Recent Ratings Updates
AstraZeneca plc was upgraded by analysts at Jefferies Group to a �buy� rating. They now have a GBX 5,000 ($80.46) price target on the stock, up previously from GBX 4,500 ($72.42).
Related articles »  
3 Neil Woodford Plays On Ageing Populations: AstraZeneca plc, Smith ...
WOODFORD Ace fund manager Neil Woodford has hammered the market over a quarter of a century. Much of his success has come from seeing 'the big picture' - and pumping money into sectors that have delivered juicy returns, while avoiding those that ...
AstraZeneca plc Rating Reiterated by Credit Suisse (AZN)
AstraZeneca plc logo Credit Suisse reissued their neutral rating on shares of AstraZeneca plc (LON:AZN) in a research note released on Thursday morning.
Nordea Equity Research Reiterates Buy Rating for AstraZeneca plc (AZN)  sleekmoney
Morningstar Assigns "AA-" Credit Rating to AstraZeneca plc (AZN)  Watch List News (press release)
Related articles »  
Weekly Analysts' Ratings Changes for AstraZeneca plc (AZN)
AstraZeneca plc was upgraded by analysts at Jefferies Group from a �hold� rating to a �buy� rating. AstraZeneca plc was upgraded by analysts at Bank of America from a �neutral� rating to a �buy� rating. AstraZeneca plc had its �neutral� rating ...
AstraZeneca plc Rating Reiterated by Deutsche Bank (AZN)
AstraZeneca plc (NYSE:AZN)'s stock had its �hold� rating reaffirmed by Deutsche Bank in a research note issued on Thursday.